The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bp Directors, Lp since 2022.
This trader's CIK number is 1813311.
At the time of last reporting, Bp Directors, Lp was the Officer of Actuate Therapeutics, Inc.. (stock ticker symbol ACTU).
Also see all insider trading activities at Actuate Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ACTU | 71,428 | $499,996 | 0 | $0 | 0 | $0 |
| 2024 | ACTU | 500,000 | $4,000,000 | 24,999 | $224,991 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | LTRN | 0 | $0 | 96,237 | $292,017 | 0 | $0 |
| 2024 | LTRN | 0 | $0 | 232,889 | $1,112,726 | 0 | $0 |
| 2023 | LTRN | 0 | $0 | 145,348 | $499,997 | 0 | $0 |
| 2022 | LTRN | 0 | $0 | 350,000 | $1,540,000 | 0 | $0 |
1. Actuate Therapeutics, Inc. (ACTU)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-27 | ACTU | Buy | 71,428 | 7.00 | 499,996 |
| 2024-08-14 | ACTU | Buy | 500,000 | 8.00 | 4,000,000 |
| 2024-08-14 | ACTU | Sale | 24,999 | 9.00 | 224,991 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | LTRN | Sale | 40,000 | 3.09 | 123,600 |
| 2025-05-28 | LTRN | Sale | 15,000 | 2.87 | 43,050 |
| 2025-05-29 | LTRN | Sale | 20,200 | 3.03 | 61,205 |
| 2025-05-27 | LTRN | Sale | 21,037 | 3.05 | 64,162 |
| 2024-05-23 | LTRN | Sale | 10,000 | 6.25 | 62,500 |
| 2024-05-24 | LTRN | Sale | 20,000 | 6.33 | 126,600 |
| 2024-02-27 | LTRN | Sale | 50,000 | 4.40 | 220,000 |
| 2024-02-28 | LTRN | Sale | 74,297 | 4.85 | 360,340 |
| 2024-02-29 | LTRN | Sale | 19,703 | 4.87 | 95,953 |
| 2024-01-17 | LTRN | Sale | 58,889 | 4.20 | 247,333 |
| 2023-11-29 | LTRN | Sale | 145,348 | 3.44 | 499,997 |
| 2022-11-08 | LTRN | Sale | 350,000 | 4.40 | 1,540,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bp Directors, Lp (Officer of Actuate Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.